whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes

Experts are debating whether angiotensin receptor blockers should be used to prevent renal problems in type 2 diabetes.

ACE inhibitors are usually the drugs of choice to prevent diabetic nephropathy. Now there's growing evidence that angiotensin receptor blockers (ARBs) also slow the progression of renal disease.

So far Cozaar (losartan) and Avapro (irbesartan) have been shown to help. The other ARBs probably give the same benefit.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote